160 related articles for article (PubMed ID: 31274223)
1. Quinolone derivatives: Potential anti-HIV agent-development and application.
Wang R; Xu K; Shi W
Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900045. PubMed ID: 31274223
[TBL] [Abstract][Full Text] [Related]
2. Quinolone hybrids and their anti-cancer activities: An overview.
Gao F; Zhang X; Wang T; Xiao J
Eur J Med Chem; 2019 Mar; 165():59-79. PubMed ID: 30660827
[TBL] [Abstract][Full Text] [Related]
3. Structural modifications of quinolone-3-carboxylic acids with anti-HIV activity.
He QQ; Gu SX; Liu J; Wu HQ; Zhang X; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Aug; 19(16):5039-45. PubMed ID: 21763149
[TBL] [Abstract][Full Text] [Related]
4. Coumarin-based derivatives with potential anti-HIV activity.
Xu Z; Chen Q; Zhang Y; Liang C
Fitoterapia; 2021 Apr; 150():104863. PubMed ID: 33582266
[TBL] [Abstract][Full Text] [Related]
5. A Review on Quinoline Derived Scaffolds as Anti-HIV Agents.
Chokkar N; Kalra S; Chauhan M; Kumar R
Mini Rev Med Chem; 2019; 19(6):510-526. PubMed ID: 30338737
[TBL] [Abstract][Full Text] [Related]
6. Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile.
Mao TQ; He QQ; Chen WX; Tang GF; Chen FE; De Clercq E; Daelemans D; Pannecouque C
Curr Pharm Des; 2016; 22(46):6982-6987. PubMed ID: 27875973
[TBL] [Abstract][Full Text] [Related]
7. Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA).
Gao C; Fan YL; Zhao F; Ren QC; Wu X; Chang L; Gao F
Eur J Med Chem; 2018 Sep; 157():1081-1095. PubMed ID: 30179746
[TBL] [Abstract][Full Text] [Related]
8. Developments of indoles as anti-HIV-1 inhibitors.
Xu H; Lv M
Curr Pharm Des; 2009; 15(18):2120-48. PubMed ID: 19519449
[TBL] [Abstract][Full Text] [Related]
9. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
[TBL] [Abstract][Full Text] [Related]
10. QSAR study and VolSurf characterization of anti-HIV quinolone library.
Filipponi E; Cruciani G; Tabarrini O; Cecchetti V; Fravolini A
J Comput Aided Mol Des; 2001 Mar; 15(3):203-17. PubMed ID: 11289075
[TBL] [Abstract][Full Text] [Related]
11. Anti-HIV diarylpyrimidine-quinolone hybrids and their mode of action.
Mao TQ; He QQ; Wan ZY; Chen WX; Chen FE; Tang GF; De Clercq E; Daelemans D; Pannecouque C
Bioorg Med Chem; 2015 Jul; 23(13):3860-8. PubMed ID: 25907370
[TBL] [Abstract][Full Text] [Related]
12. Studies of anti-HIV transcription inhibitor quinolones: identification of potent N1-vinyl derivatives.
Tabarrini O; Massari S; Daelemans D; Meschini F; Manfroni G; Bottega L; Gatto B; Palumbo M; Pannecouque C; Cecchetti V
ChemMedChem; 2010 Nov; 5(11):1880-92. PubMed ID: 20928882
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of HQCAs with aryl or benzyl substituents on N-1 position as potential HIV-1 integrase inhibitors.
He QQ; Zhang X; Wu HQ; Gu SX; Ma XD; Yang LM; Zheng YT; Chen FE
Bioorg Med Chem; 2011 Sep; 19(18):5553-8. PubMed ID: 21862337
[TBL] [Abstract][Full Text] [Related]
14. Quinolone derivatives and their antifungal activities: An overview.
Zhang B
Arch Pharm (Weinheim); 2019 May; 352(5):e1800382. PubMed ID: 31021468
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study on anti-HIV 6-desfluoroquinolones.
Tabarrini O; Massari S; Daelemans D; Stevens M; Manfroni G; Sabatini S; Balzarini J; Cecchetti V; Pannecouque C; Fravolini A
J Med Chem; 2008 Sep; 51(17):5454-8. PubMed ID: 18710207
[TBL] [Abstract][Full Text] [Related]
16. 14-Formyl-15-aryloxy/methoxymatrine and 14-Aryloxymethylidenyl-matrine Derivatives as Anti-HIV-1 Agents.
Huang J; Xiang SY; Lv M; Yang LM; Zhang Y; Zheng YT; Xu H
Med Chem; 2018; 14(3):249-252. PubMed ID: 28969577
[TBL] [Abstract][Full Text] [Related]
17. New quinolone antibiotics: a survey of the literature from 2005 to 2010.
Wiles JA; Bradbury BJ; Pucci MJ
Expert Opin Ther Pat; 2010 Oct; 20(10):1295-319. PubMed ID: 20645884
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives.
Santos Fda C; Abreu P; Castro HC; Paixão IC; Cirne-Santos CC; Giongo V; Barbosa JE; Simonetti BR; Garrido V; Bou-Habib DC; Silva Dde O; Batalha PN; Temerozo JR; Souza TM; Nogueira CM; Cunha AC; Rodrigues CR; Ferreira VF; de Souza MC
Bioorg Med Chem; 2009 Aug; 17(15):5476-81. PubMed ID: 19581097
[TBL] [Abstract][Full Text] [Related]
19. Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands.
Sancineto L; Iraci N; Barreca ML; Massari S; Manfroni G; Corazza G; Cecchetti V; Marcello A; Daelemans D; Pannecouque C; Tabarrini O
Bioorg Med Chem; 2014 Sep; 22(17):4658-66. PubMed ID: 25127466
[TBL] [Abstract][Full Text] [Related]
20. Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: evaluation of new 6-desfluoroquinolone derivatives.
Stevens M; Pollicita M; Pannecouque C; Verbeken E; Tabarrini O; Cecchetti V; Aquaro S; Perno CF; Fravolini A; De Clercq E; Schols D; Balzarini J
Antimicrob Agents Chemother; 2007 Apr; 51(4):1407-13. PubMed ID: 17242146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
